Similar to other tumor types, prostate cancer is becoming molecularly stratified to identify targeted
status (overexpressed, ARv7), however new molecular pathways are being determined as having a
major role in prostate molecular pathogenesis, with potential treatment impact.
Publications
Genomic and protein alterations in 126 triple-negative (TN) metaplastic breast cancers
– Caris Life Sciences